A vital activity of the ID division is laboratory, translational, and clinical research. The division’s research portfolio includes awards from the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), Health Resources and Services Administration (HRSA), United States Agency for International Development (USAID), foundations, and industry sponsors. The division also conducts numerous UPMC clinical trials. Strong research themes in the division include HIV-AIDS, epidemiology and molecular epidemiology of bacterial pathogens, antimicrobial resistance of gram-negative bacteria, pathogenesis of fungal infections, and biosecurity planning.
Research activities are concentrated in three world-class Centers of Excellence in Research: 1) The Center for Antibody Therapeutics (CAT), which identifies, characterizes and engineers novel human monoclonal antibodies (mABs) as candidate therapeutics; 2) the Center for Innovative Antimicrobial Therapy (CIAT) investigates novel approaches to combat the growing problem of antimicrobial resistance.; and 3) the Center for AIDS Elimination (CAE), which provides clinical, educational, and scientific research for the purposes of prevention, treatment and cure of HIV/AIDS.



Antimicrobial Resistance


Medical Mycology


Genomic Epidemiology


Host-Immune Response


Antibody Therapeutics

Division of Infectious Diseases
Academic Administrative Office

818 Scaife Hall
3550 Terrace Street
Pittsburgh, PA 15261
Academic Office: 412-383-9062

For Patients: 412-647-7228

Center for Care of Infectious Diseases

Falk Medical Building
3601 Fifth Avenue, 7th Floor
Pittsburgh, PA 15213

Patient Appointments: 412-647-7228

Main CCID Fax: 412-647-7951